Holen Sie sich die Stockscreener-App
1.22
2.40%
-0.03
Handel nachbörslich:
1.20
-0.02
-1.64%
Schlusskurs vom Vortag:
$1.25
Offen:
$1.2791
24-Stunden-Volumen:
30,911
Relative Volume:
0.33
Marktkapitalisierung:
$3.30M
Einnahmen:
$832.80K
Nettoeinkommen (Verlust:
$-21.55M
KGV:
-0.1013
EPS:
-12.0465
Netto-Cashflow:
$-12.71M
1W Leistung:
+25.70%
1M Leistung:
-38.07%
6M Leistung:
-70.39%
1J Leistung:
-92.38%
1-Tages-Spanne:
$1.215
$1.28
1-Wochen-Bereich:
$0.98
$1.35
52-Wochen-Spanne:
$0.9532
$41.20
Hcw Biologics Inc Stock (HCWB) Company Profile
Firmenname
Hcw Biologics Inc
Sektor
Branche
Telefon
954-842-2024
Adresse
2929 N COMMERCE PKWY, MIRAMAR
Vergleichen Sie HCWB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCWB
Hcw Biologics Inc
|
1.22 | 3.38M | 832.80K | -21.55M | -12.71M | -12.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Hcw Biologics Inc Aktie (HCWB) Neueste Nachrichten
Is HCW Biologics Inc. stock recession proofQuarterly Trade Review & Free Real-Time Market Sentiment Alerts - ulpravda.ru
HCW Biologics reports steps to regain Nasdaq compliance following equity transactions - Investing.com
HCW Biologics reports steps to regain Nasdaq compliance following equity transactions By Investing.com - Investing.com South Africa
HCW Biologics Restructures Obligations to Regain Nasdaq Compliance - TipRanks
HCW Biologics Achieves Nasdaq Compliance Milestone - TradingView — Track All Markets
Returns Recap: Will HCW Biologics Inc stock attract ESG investorsEarnings Beat & Daily Price Action Insights - moha.gov.vn
HCW Biologics Granted Nasdaq Compliance Extension - MSN
Aug Analyst Calls: Is HCW Biologics Inc stock recession proofGDP Growth & AI Enhanced Trade Execution Alerts - moha.gov.vn
US Market Recap: How analysts rate HCW Biologics Inc stock todayWeekly Investment Summary & Precise Buy Zone Identification - moha.gov.vn
HCW Biologics (NASDAQ:HCWB) Shares Down 0.2% – Time to Sell? - Defense World
Reviewing HCW Biologics (NASDAQ:HCWB) and ImmunityBio (NASDAQ:IBRX) - Defense World
HCW Biologics Earnings Notes - Trefis
Is HCW Biologics Inc. stock gaining market shareJuly 2025 Opening Moves & Verified Momentum Stock Ideas - Улправда
Is HCW Biologics Inc. stock attractive for growth ETFsMarket Performance Report & Low Drawdown Investment Ideas - Улправда
Is HCW Biologics Inc. stock a buy in volatile markets2025 Price Targets & Long Hold Capital Preservation Plans - Улправда
How analysts rate HCW Biologics Inc. stock todayJuly 2025 Snapshot & Weekly High Return Stock Forecasts - Bölüm Sonu Canavarı
Can HCW Biologics Inc. stock deliver consistent earnings growthMarket Activity Summary & AI Forecasted Entry/Exit Points - DonanımHaber
Can HCW Biologics Inc. stock deliver strong Q4 earningsMarket Activity Report & Community Trade Idea Sharing - bolumsonucanavari.com
HCW Biologics Inc Stock Analysis and ForecastREITs Market Trends & Investment Timing Techniques - earlytimes.in
Will HCW Biologics Inc. stock benefit from sector rotationJuly 2025 Sentiment & Long-Term Safe Investment Plans - Newser
Is HCW Biologics Inc. overvalued or undervalued? - Markets Mojo
HCW Biologics Amends License Agreement with Trimmune - MSN
How HCW Biologics Inc. stock performs in rate cut cyclesQuarterly Earnings Report & Real-Time Volume Analysis - Newser
HCW Biologics (NASDAQ:HCWB) Trading Down 7.1% – Here’s What Happened - Defense World
HCW Biologics (HCWB) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Hedge Fund Bets: Why HCW Biologics Inc. stock is seen as undervaluedPortfolio Growth Summary & Weekly Chart Analysis and Guides - moha.gov.vn
Form 8-KCurrent report - ADVFN
Form 10-QQuarterly report [Sections 13 or 15(d)] - ADVFN
HCW Biologics Reports Third Quarter 2025 Business Highlights and Financial Results - ADVFN
HCW Biologics Inc. (HCWB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
HCW Biologics Secures $4M Through Warrant Exercise - MSN
Why HCW Biologics Inc. stock attracts high net worth investorsMarket Trend Report & Fast Momentum Stock Entry Tips - newser.com
Is HCW Biologics Inc. stock positioned well for digital economyMarket Movers & Safe Entry Trade Reports - newser.com
Will HCW Biologics Inc. stock benefit from infrastructure spending2025 Valuation Update & Reliable Volume Spike Trade Alerts - newser.com
HCW Biologics Begins Phase 1 Trial for HCW9302 - MSN
[8-K] HCW Biologics Inc. Reports Material Event | HCWB SEC FilingForm 8-K - Stock Titan
Insiders' US$3.05m Investments In Red Following HCW Biologics' US$1.1m Dip In Market Value - simplywall.st
What analysts say about HCW Biologics Inc stockSector Rotation Strategies & Low Risk Trading Growth - earlytimes.in
Why retail investors favor HCW Biologics Inc. stockShort Setup & Daily Oversold Stock Bounce Ideas - newser.com
HCW Biologics secures $4 million through warrant exercise agreement By Investing.com - Investing.com Nigeria
HCW Biologics enters amended licensing agreement with Beijing Trimmune Biotech - Investing.com Nigeria
Using fundamentals and technicals on HCW Biologics Inc.Market Performance Recap & Real-Time Volume Surge Alerts - newser.com
Hcw Biologics announces warrant inducement agreement - MarketScreener
HCW Biologics secures $4 million through warrant exercise agreement - Investing.com
HCW Biologics Enters into $4.0 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules - The Manila Times
Finanzdaten der Hcw Biologics Inc-Aktie (HCWB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.80%
4.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):